Question to the Department of Health and Social Care:

To ask His Majesty's Government how many commercial agreements NHS England has made with manufacturers of medicines which allow, support or result in non-uniform pricing by individual medicine.

Since April 2020, NHS England has agreed to 37 commercial agreements that have resulted in non-uniform pricing by medicine, via either the Cancer Drugs Fund, or through bespoke commercial deals to support routine commissioning.